Non-Hodgkin lymphoma is the 11th most common cause of cancer death in the UK, accounting for 3% of all cancer deaths (2017).[1-3]
In females in the UK, non-Hodgkin lymphoma is the 10th most common cause of cancer death (3% of all female cancer deaths). In males in the UK it is the 14th most common cause of cancer death (3% of all male cancer deaths).
46% of non-Hodgkin lymphoma deaths in the UK are in females, and 54% are in males.
Non-Hodgkin lymphoma mortality rates (European age-standardised
Non-Hodgkin Lymphoma (C82-C86), Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK, 2017
|AS Rate - 95% LCL||6.1||6.0||4.6||5.1||6.2|
|AS Rate - 95% UCL||6.7||7.9||6.9||8.4||6.7|
|AS Rate - 95% LCL||9.4||8.2||8.1||7.0||9.4|
|AS Rate - 95% UCL||10.2||10.8||11.3||11.5||10.1|
|AS Rate - 95% LCL||7.7||7.3||6.5||6.6||7.7|
|AS Rate - 95% UCL||8.2||8.9||8.4||9.3||8.1|
- Data were provided by the Office for National Statistics on request, November 2018. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
- Data were provided by ISD Scotland on request, October 2018. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
- Data were provided by the Northern Ireland Cancer Registry on request, March 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.
About this data
Data is for UK, 2017, ICD-10 C82-C86.
The term non-Hodgkin lymphoma describes a large group of lymphoma subtypes, which differ substantially in their cellular origin and clinical behaviour. The subtypes can be broadly divided into B-cell lymphomas, T-cell lymphomas, and lymphoproliferative disorders not otherwise specified. B-cell lymphomas can be further divided into five main types: diffuse large B-cell lymphoma, marginal zone lymphomas, follicular lymphoma, mantle cell lymphoma, and Burkitt lymphoma. It is important to recognise the variation between these subtypes when interpreting statistics on NHL as a whole. The Haematological Malignancy Research Network provides detailed incidence statistics for NHL subtypes.